コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 -regulating endopeptidase homolog), and Bsp (bone sialoprotein).
2 nimal role in mediating the PTH induction of bone sialoprotein.
3 (HA)-binding properties and bone tropism to bone sialoprotein.
4 ontain high levels of sialic acid similar to bone sialoprotein.
5 as Col10, osterix, alkaline phosphatase, and bone sialoprotein.
7 veral bone-associated proteins (osteopontin, bone sialoprotein, alkaline phosphatase, type I collagen
8 els prominently accelerated collagen type I, bone sialoprotein and osteocalcin protein expression.
9 rkers of osteoblastic differentiation (i.e., bone sialoprotein and osteocalcin) in the preosteoblasts
11 ment normalized the altered distributions of bone sialoprotein and osteopontin in Hyp mouse alveolar
12 osteocyte marker), while osteoblast markers, bone sialoprotein and osteopontin, remained unchanged.
13 ndicated that BMP-2 decreased mRNA levels of bone sialoprotein and type I collagen dose-dependently (
14 e increases in the expression of major bone (bone sialoprotein) and cartilage (type II collagen) matr
15 differentiation markers such as osteocalcin, bone sialoprotein, and dentin matrix protein 1 (DMP1) wa
17 ciated with significant reductions in Runx2, bone sialoprotein, and osteocalcin expression, parallele
19 N-linked glycoproteins) family of proteins, bone sialoprotein, and osteopontin, bound first to a cel
20 the osteogenic markers alkaline phosphatase, bone sialoprotein, and Runt-related transcription factor
21 total NCPs were separated into osteopontin-, bone sialoprotein-, and dentin matrix protein-1-enriched
24 ted transcription factor 2 at 7 days and for bone sialoprotein at days 7 and 10 as well as higher OPN
25 sized that the Staphylococcus aureus MSCRAMM bone sialoprotein-binding protein (Bbp) might recognize
26 gulase, exotoxin, Ser-Asp fibrinogen-binding bone sialoprotein-binding protein, fibrinogen and kerati
27 d osteonectin, whereas alkaline phosphatase, bone sialoprotein, bone Gla protein, and collagen II, al
31 DGF-BB or TGF-beta resulted in a decrease in bone sialoprotein (BSP) and osteocalcin (OCN) mRNAs whil
32 n situ hybridization, for gene expression of bone sialoprotein (BSP) and osteocalcin (OCN), and histo
33 Alendronate suppressed the expression of bone sialoprotein (BSP) and osteonectin in both femurs a
34 lecules associated with mineralized tissues, bone sialoprotein (BSP) and osteopontin (OPN), and a cel
36 inical correlation between the expression of bone sialoprotein (BSP) and skeletal metastasis of breas
37 nohistochemistry methods were used to detect bone sialoprotein (BSP) distribution in Hyp and WT mouse
38 study to determine the relationship between bone sialoprotein (BSP) expression and osteocalcin expre
39 ted growth and enhanced osteocalcin (OC) and bone sialoprotein (BSP) gene expression in human prostat
43 llular phosphoproteins osteopontin (OPN) and bone sialoprotein (BSP) have been implicated in biologic
44 linked glycoproteins), osteopontin (OPN) and bone sialoprotein (BSP) in the Galnt1-null mice relative
53 ssociated proteins, i.e., osteopontin (OPN), bone sialoprotein (BSP), alkaline phosphatase (ALP), ost
54 aining bone acidic glycoprotein-75 (BAG-75), bone sialoprotein (BSP), and alkaline phosphatase that a
55 runt-related transcription factor 2 (RunX2), bone sialoprotein (BSP), and osteocalcin (OCN) messenger
58 ING proteins: full-length osteopontin (OPN), bone sialoprotein (BSP), dentin matrix protein 1 (DMP1),
59 nsfer and expression of osteocalcin (OC) and bone sialoprotein (BSP), genes pivotal to bone matrix fo
60 ion of a mineralized tissue-specific marker, bone sialoprotein (BSP), indicating that epithelial prod
62 levels of mineral-associated genes including bone sialoprotein (BSP), OC, and osteopontin (OPN) in th
63 Proliferating cell nuclear antigen (PCNA), bone sialoprotein (BSP), osteocalcin (OCN), and tartrate
64 ed cementoblast population (OC/CM) expressed bone sialoprotein (BSP), osteopontin (OPN), and OC, mark
65 of mineralized tissue-associated markers of bone sialoprotein (BSP), Type I collagen (COL I), osteoc
70 prove this hypothesis, we infected 5-day-old bone sialoprotein (BSP)/avian retroviral receptor gene (
72 ays for core binding factor alpha-1 [Cbfa1], bone sialoprotein [BSP], osteocalcin [OCN], and osteopon
73 rkers (osteocalcin [OCN], osteopontin [OPN], bone sialoprotein [BSP], osteoprotegerin [OPG] and recep
74 s: bone marrow mesenchymal stem cell, BMMSC; bone sialoprotein, BSP; hydroxyapatite/tricalcium phosph
75 ly of integrin-binding phosphoglycoproteins (bone sialoprotein, BSP; osteopontin, OPN; and dentin mat
76 target genes, osteocalcin, osteopontin, and bone sialoprotein but did not significantly alter Runx2
77 and a significant decrease in expression of bone sialoprotein, characteristics of periodontal ligame
78 moted with AMC spheroids/FDBG treatment, and bone sialoprotein expression and cell proliferation were
79 o OSE2 preceded increases in osteocalcin and bone sialoprotein expression and this increase in Osf2 b
80 , these results suggest that osteocalcin and bone sialoprotein expression is coordinated and regulate
81 study is to investigate how osteocalcin and bone sialoprotein expression is regulated in prostate ca
82 ed osteopontin and osteocalcin and decreased bone sialoprotein expression was detected within 7 days
84 conditioned medium-mediated osteocalcin and bone sialoprotein gene expression in prostate cancer cel
85 In differentiated MC4 cells, osteocalcin and bone sialoprotein gene expression were both down-regulat
86 evelopment (e.g. Col1a1, Postn/Osf2, and the bone sialoprotein gene or BSP), genes that are expressed
88 transcription factor in the osteocalcin and bone sialoprotein genes that cannot be resolved by tradi
89 ssion of osteoblast-specific osteocalcin and bone sialoprotein genes, alkaline phosphatase activity,
90 g the alkaline phosphatase, osteocalcin, and bone sialoprotein genes, and temporally associates with
91 trix phosphoproteins such as osteopontin and bone sialoprotein have yielded important biological info
92 t differentiation genes osterix (Sp7), Atf4, bone sialoprotein (Ibsp), and osteocalcin (Bglap) withou
94 tein (DSPP), dentin matrix protein 1 (DMP1), bone sialoprotein II (IBSP), and bone morphogenetic prot
95 line phosphatase/ALPL, osteopontin/SPP1, and bone sialoprotein II/IBSP) in a subset of the hMSC popul
96 ne phosphatase), Ocn (osteocalcin), and Bsp (bone sialoprotein) in response to recombinant PP and sta
100 AP could promote periodontal regeneration in bone sialoprotein knockout mice (Ibsp(-/-) mice), which
102 at calcium deposition and gene expression of bone sialoprotein, lipoprotein lipase, and fatty acid bi
103 A1 and osteocalcin mRNA levels and increased bone sialoprotein mRNA, consistent with an inhibition of
104 -fold increase in the steady-state levels of bone sialoprotein mRNAs within primary cultures of embry
105 ophages in response to added native purified bone sialoprotein (nBSP) and its dephosphorylated form (
106 versus normal human valves for osteopontin, bone sialoprotein, osteocalcin, alkaline phosphatase, an
107 educed osterix-producing cells and increased bone sialoprotein, osteocalcin, and BMP-7 expression.
108 vealed increased mRNA levels of osteopontin, bone sialoprotein, osteocalcin, and Cbfa1 in the calcifi
110 ogenic markers such as Runx2, Osterix, DMP1, Bone sialoprotein, Osteocalcin, NFATc1, and Schnurri-2,
111 ranscription factor 2, Type I collagen, ALP, bone sialoprotein, osteopontin), osteocalcin, CEMP1, and
112 ng ligand N-linked glycoproteins (SIBLINGs): bone sialoprotein, osteopontin, and dentin matrix protei
113 ulation of interleukin-6, interleukin-1beta, bone sialoprotein, osteoprotegerin, receptor activator o
114 g demonstrated that a sizeable proportion of bone sialoprotein particles were located within a 50-nm
115 tion revealed that (a) human osteocalcin and bone sialoprotein promoter activities in an androgen-ind
116 ediated stimulation of human osteocalcin and bone sialoprotein promoter activities occurs through inc
117 um was found to induce human osteocalcin and bone sialoprotein promoter activities via increased CRE/
119 of an osteoblast-specific element within the bone sialoprotein promoter and demonstrate its regulatio
120 ) Deletion analysis of human osteocalcin and bone sialoprotein promoter regions identified cyclic AMP
121 tronectin, type I collagen, osteopontin, and bone sialoprotein) showed any detectable effect on PG me
123 alkaline phosphatase, bone Gla protein, and bone sialoprotein, suggesting an osteogenic phenotype.
125 nding of the Col11a1 "6b" exonal sequence to bone sialoprotein was demonstrated with overlapping pept
126 ble in both genotypes, and the expression of bone sialoprotein was similar in tumor-bearing bones of
128 tic protein (BMP)-2, BMP-7, osteopontin, and bone sialoprotein were evaluated in alveolar sockets.
129 bone proteins, osteopontin, osteonectin, and bone sialoprotein, were identified in the protein extrac
130 ion factor 2), osteocalcin, osteopontin, and bone sialoprotein, were reduced proportionate to the red
131 n the pro-adhesive molecules osteopontin and bone sialoprotein, which is in contrast to the high leve